Microfinance in Bolivia: A Meeting with the President of the Republic

Michael  Chu

Case | HBS Case Collection | April 2007

Microfinance in Bolivia: A Meeting with the President of the Republic

Abstract

Herbert Muller, chair of leading microfinance bank BancoSol, has met with Evo Morales one year after the populist leader's inauguration as president of Bolivia and proceeds to write an email to his fellow board directors. The bank is world famous for pioneering microfinance while delivering superior financial performance. Evo Morales is an Amerindian who supporters see as a response to the white oligarchy that has long dominated Bolivia and as a champion of the downtrodden, in the poorest country in South America. In the first year of his administration, he has nationalized the oil and gas industry, created a constituent assembly to rewrite the constitution, and launched agrarian reform. The meeting between Muller and Morales takes place at the Bolivian banking association where the government officials, while committing not to mandate the reduction of interest rates in microcredit, express their expectation that rates will drop as quickly as possible. A week earlier, senior cabinet officials had met with the president of the banking association and expressed their wish that interest rates for loans in the banking system would decline to single digits.

Keywords: Risk and Uncertainty; Race; Government Administration; Business and Government Relations; Microfinance; Poverty; Interest Rates; Banks and Banking; Financial Services Industry; Bolivia; South America;

Format: Print

5 pages

Find at Harvard

Citation:

Chu, Michael. "Microfinance in Bolivia: A Meeting with the President of the Republic." Harvard Business School Case 307-107, April 2007.

With a breakthrough cure for Hepatitis C listing in the U.S. at $1,000/pill, Gilead must now solve the issue of making it available to patients across the world, much as it did for its blockbuster HIV/AIDS antiretrovirals. For Erik Musalem, the new general manager of Gilead Mexico, the challenge was complicated by operating in a middle-income country, where Gilead’s terms for more vulnerable nations did not apply. For all practical purposes, Musalem had only one customer for his company’s Hep C medicine: Mexico’s public health system and the National Pricing Commission that set prices annually for the entire sector. With no lack of priorities competing for the finite resources of the public health sector, Musalem’s charge was to devise the strategy that in the long run would maximize access to the cure in Mexico while protecting the financial strength of Gilead Sciences, Inc.

In the fall of 2017, self-made business leader Edgardo Novick pondered his campaign to be elected President of Uruguay, “the Switzerland of Latin America.” Inspired by populist revolts against the status quo observable worldwide, Novick hoped he could ride popular momentum to break the political monopoly of the traditional parties and return the country to its past greatness. Uruguay had been one of the world’s most successful countries in the nineteenth and early twentieth centuries but had since experienced a long period of relative decline. Could Novick’s campaign turn the tide of history? And what policy should Uruguay adopt with regard to the world economy?

Faculty & Research

Microfinance in Bolivia: A Meeting with the President of the Republic

Abstract

Citation:

About the Author

More from the Author